Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Adam Cribbs has been awarded a prestigious MRC Career Development Award to further his research to identify therapeutic targets for multiple myeloma.

Adam Cribbs

Multiple myeloma (MM) is a cancer of plasma cells that has a varied response rate to treatment and a survival rate of 4-5 years. Poor survival has been attributed to drug resistance therefore identification of novel therapeutic targets for MM that overcome drug resistance is critical.

The MRC Career Development Awards, which are offered to support talented researchers to lead their own research, will enable Adam to build on his research interests in systems biology, immunology and epigenetics.

Specifically, he will develop novel, cost-effective multiplexed single-cell technologies that will provide an understanding of the relationship between the immune system and the MM tumour macroenvironment.

Commenting on his award Adam said: “I’m so pleased to have been offered the MRC award. We need to understand the cellular mechanisms that contribute to drug resistance within MM to be able to deliver better treatments. This award reinforces my belief that in time we will be able to expand the number of potential drug targets for MM, improving quality and longevity of life for patients.”

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.